Skip to main content
    G

    Goodrx Holdings Inc (GDRX)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $3.51
    -0.05 (-1.40%)

    Market Cap: $1.21B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Goodrx Holdings Inc (GDRX) Financials: Revenue, Profit and Cash Flow

    Updated Aug 5, 2026. Financial statements from company filings, amounts in US dollars.

    Goodrx Holdings reported revenue of $796.85M for the fiscal year ended Dec 31, 2025, up 0.6% from the year before. That year, net income was $30.44M with a net margin of 3.8%, operating cash flow was $167.90M and free cash flow was $93.88M. The quarter ended Jun 30, 2026 had revenue of $200.41M and net income of $8.54M.

    Revenue and Margins

    The operating margin was 11.0% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $99.38M, a compound annual rate of 26.0%.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$796.85M+0.6%92.8%11.0%3.8%
    Dec 2024$792.32M+5.6%93.9%8.3%2.1%
    Dec 2023$750.26M-2.1%91.1%-3.6%-1.2%
    Dec 2022$766.55M+2.8%91.5%0.2%-4.3%
    Dec 2021$745.42M+35.4%93.7%1.8%-3.4%
    Dec 2020$550.70M+41.9%94.6%-50.1%-53.3%
    Dec 2019$388.22M+55.6%96.4%36.0%19.5%
    Dec 2018$249.52M+58.7%97.6%31.0%17.6%
    Dec 2017$157.24M+58.2%92.3%32.0%5.6%
    Dec 2016$99.38MN/A89.6%19.0%-7.8%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, net income rose 85.7% from the year before. In the quarter ended Jun 2026, net income fell 33.5% from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$796.85M$792.32M$750.26M$766.55M$745.42M$550.70M$388.22M$249.52M$157.24M$99.38M
    Cost of revenue$57.60M$48.22M$66.92M$65.08M$46.72M$29.59M$14.02M$6.04M$12.17M$10.32M
    Gross profit$739.26M$744.11M$683.34M$701.48M$698.71M$521.11M$374.21M$243.49M$145.07M$89.06M
    Research and development$121.03M$123.75M$135.84M$143.14M$125.86M$61.82M$29.30M$43.89M$11.50M$5.74M
    Operating income$87.49M$65.85M-$27.01M$1.74M$13.41M-$275.72M$139.68M$77.25M$50.31M$18.92M
    Net income$30.44M$16.39M-$8.87M-$32.83M-$25.25M-$293.62M$75.80M$43.79M$8.84M-$7.77M
    EBITDA$175.20M$135.22M$80.03M$59.33M$51.39M-$253.92M$153.66M$88.29M$59.41M$28.01M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Revenue$200.41M$194.01M$194.78M$196.03M$203.07M$202.97M$198.58M$195.25M$200.61M$197.88M$196.64M$179.96M
    Gross profit$179.41M$173.85M$177.32M$182.61M$189.72M$189.61M$186.39M$183.57M$188.74M$185.41M$181.47M$161.24M
    Operating income$23.63M$14.01M$22.68M$14.62M$26.81M$23.38M$18.18M$20.41M$19.88M$7.38M-$18.29M-$38.33M
    Net income$8.54M$1.17M$5.42M$1.12M$12.84M$11.05M$6.74M$3.96M$6.69M-$1.01M-$25.87M-$38.49M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $488.26M exceeded cash and equivalents by $226.44M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$1.40B$1.39B$1.59B$1.60B$1.61B$1.47B$386.80M$314.79M$286.87M$295.65M
    Current assets$643.10M$659.25M$872.79M$919.69M$1.09B$1.09B$86.58M$73.07MN/AN/A
    Cash and equivalents$261.82M$448.35M$672.30M$757.16M$941.11M$968.69M$26.05M$34.60M$17.54M$23.61M
    Total liabilities$787.80M$663.41M$826.84M$789.80M$775.95M$758.75M$737.37M$1.48B$136.01M$46.08M
    Short-term debt$5.00M$5.00M$8.79M$7.03M$7.03M$7.03M$7.03M$5.43MN/AN/A
    Long-term debt$483.26M$486.71M$647.70M$651.80M$655.86M$659.89M$663.89M$716.81MN/AN/A
    Shareholder equity$616.26M$724.66M$761.96M$814.83M$831.68M$711.36M-$1.09B-$1.16B-$86.19M$8.11M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total assets$2.34B$2.02B$1.40B$1.33B$1.32B$1.30B$1.39B$1.35B$1.48B$1.45B$1.59B$1.71B
    Total liabilities$1.70B$1.40B$787.80M$724.79M$675.67M$640.92M$663.41M$658.41M$805.99M$822.89M$826.84M$826.70M
    Cash and equivalents$296.11M$235.71M$261.82M$273.53M$281.32M$300.98M$448.35M$423.78M$524.90M$533.29M$672.30M$794.90M
    Shareholder equity$647.60M$621.99M$616.26M$600.71M$643.03M$654.35M$724.66M$696.43M$669.40M$631.07M$761.96M$881.27M
    Last 12 quarters

    Cash Flow

    In the fiscal year ended Dec 2025, free cash flow was 55.9% of operating cash flow. Share repurchases came to 230.5% of it.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
    Operating cash flow$167.90M$183.89M$138.29M$146.78M$178.78M$131.34M$83.29M$45.25M
    Capital expenditures$74.02M$70.35M$55.77M$55.21M$34.46M$35.82M$5.75M$3.46M
    Free cash flow$93.88M$113.55M$82.53M$91.57M$144.32M$95.52M$77.54M$41.80M
    Dividends paidN/AN/A$1N/A$22.67M$78.71M$0$1.35B
    Share repurchases$216.37M$158.84M$103.97M$101.72M$0$4.94M$0$0
    Investing cash flow-$119.96M-$70.35M-$55.77M-$210.50M-$178.73M-$91.62M-$37.05M-$3.46M
    Financing cash flow-$234.47M-$337.50M-$167.40M-$120.23M-$30.53M$905.82M-$54.78M-$24.73M
    Fiscal years ended Dec 2018 to Dec 2025

    Quarterly

    Line itemJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Operating cash flow$80.83M$11.84M$32.89M$76.02M$49.58M$9.41M$44.74M$86.86M$9.70M$42.59M$15.87M$60.27M
    Capital expenditures$14.41M$21.64M$15.83M$18.00M$18.32M$21.88M$16.64M$15.86M$17.23M$20.61M$12.87M$13.65M
    Free cash flow$66.42M-$9.81M$17.06M$58.02M$31.27M-$12.46M$28.10M$71.00M-$7.53M$21.97M$3.00M$46.62M
    Last 12 quarters

    Frequently Asked Questions About GDRX

    What is Goodrx Holdings' annual revenue?

    Goodrx Holdings reported revenue of $796.85M for the fiscal year ended Dec 31, 2025.

    How fast is Goodrx Holdings' revenue growing?

    Revenue was up 0.6% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 1.3%.

    Is Goodrx Holdings profitable?

    Yes. Goodrx Holdings reported net income of $30.44M for the fiscal year ended Dec 31, 2025, with a net margin of 3.8%.

    How much free cash flow does GDRX generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of $167.90M minus capital expenditures of $74.02M produced free cash flow of $93.88M.

    How much debt does Goodrx Holdings have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $483.26M, short-term debt of $5.00M and cash and equivalents of $261.82M.